Great lineup!

Contrats to Maggie Margaret Axelrod, MD, PhD! Real pleasure to work w/ and learn from her & BalkoResearchLab for the last 4 years! Making great impact in #CardioOnc & helping understand basic mechanisms of ICI-myocarditis! Vanderbilt MSTP Juan Qin, PhD Wouter Meijers DrJE-Salem

Heart Failure is more than meets the eye. High comorbidity burden, and obesity is on the rise. Read our latest interesting article comparing two cohorts 15 years apart. UMCG Cardiology Research Institute Rudolf de Boer Daan Westenbrink Tiny Jaarsma Clin Res Cardiol. link.springer.com/content/pdf/10…

Insulin‐like growth factor binding protein 7 (IGFBP7) is an independent prognostic biomarker in 2516 BIOSTAT heart failure patients (with external validation in 1738 HF patients). IGFBP7 as a link between HF, immune response, and senescence onlinelibrary.wiley.com/doi/10.1002/eh…

CardioImmunology meets CardioOncology. Terrific talk by Javid Moslehi Javid Moslehi about Checkpoint Myocarditis Mouse Models Unispital_USZ #ICI #Immunotherapy

UCSF #CardioOnc conference this week! Amir Munir presenting on RAF/MEKi Cardiotoxicity. Welcoming back UCSF Cardiology Fellows graduate & UNC School of Medicine Prof Brian Jensen! Ethan J. Weiss Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA Mandar Aras, MD, PhD Alan Baik Yen-Chou (YC) Chen @EimanJahangir Novartis Cancer jaya-mallidi Wouter Meijers

Can immune checkpoints be a target in cardiovascular disease? Great overview by Laura Yousif, PhD in our Cardio-Onc group. frontiersin.org/articles/10.33… Rudolf de Boer UMCG Cardiology Research Institute UMC Utrecht International International Cardio-Oncology Society

Very happy to share our work on T cells in one of the deadliest side effects of anti-cancer therapy, immune checkpoint inhibitor-myocarditis out today in nature mentored by BalkoResearchLab Javid Moslehi ; read on for a short summary! Vanderbilt MSTP nature.com/articles/s4158…

Extremely grateful for the all-star team of co-authors and supporters who made this work possible! BalkoResearchLab Javid Moslehi Wouter Meijers Juan Qin, PhD Xiaopeng Elie Tannous, MD Ayaka Sugiura Brandie Taylor Shaoyi Zhang Kaushik Amancherla JordanJWright Jeff Rathmell Ferrell Lab Jim Allison PhD

A new publication from our cardio-oncology (SECRETE-HF) group ! Canxia Shia et al. have investigated the role of Clonal haematopoiesis of indeterminate potential in the context of heart, check this thread Wouter Meijers Rudolf de Boer Joseph Pierre Aboumsallèm #MondayScientificSnack #HF

I’m boycotting windmills after this match. Never again will I say “oh look, a windmill!” I won’t even use fans. Cartwheels are now forbidden in this household.

Do you want to listen to Pietro Ameri and myself discussing the topic @ ESC Cardio Talk podcast? Thank you for the opportunity. EHJ Editor-in-Chief Erasmus MC escardio.libsyn.com/journal-editor…

In a new episode of #ESCCardioTalk, Pietro Ameri and Wouter Meijers discuss: Cancer is a comorbidity of heart failure Listen now bit.ly/3HIIV9O #heartfailure #cancer #cardiotwitter #CVD #EHJ

Multi-omics analyses identify molecular signatures with prognostic values in different heart failure aetiologies Read in our February issue: doi.org/10.1016/j.yjmc…

Looking forward to the Global CardioOncology Summit 2023 in #Madrid! #GCOS2023 #CardioOnc International Cardio-Oncology Society

Great and inspiring Cardio-onco (and reverse..)session today at the Dutch-German joint meeting Deutsches Zentrum für Herzinsuffizienz! Chaired by Wouter Meijers AG40 - Onkologische Kardiologie Deutsche Gesellschaft für Kardiologie Johannes Backs

Congrats 2 our #CardioOnc alumnus, Dr. Wouter Meijers Wouter Meijers for senior authoring this terrific manuscript on the role in immune checkpoints in heart failure! Rudolf de Boer DrJE-Salem #HFA_ESC HFAPresident European Society of Cardiology News European Society of Cardiology UCSF Cardiology onlinelibrary.wiley.com/doi/10.1002/eh…

Finally, We will have a thrilling close to the research symposium with 3 riveting cardio-oncology tracks at #GCOS23 Navigate the mechanisms of cardiotoxicity, delve into preclinical & clinical data on immunotherapy & inflammation, and uncover the mysteries of various toxicities!!

Are we close to unravel underlying mechanisms and targets for cardio-oncology patients? How do we need to use biomarkers in this field? New insights in JACC: CO jacc.org/doi/10.1016/j.… JACC Journals International Cardio-Oncology Society Rudolf de Boer Javid Moslehi Joseph Pierre Aboumsallèm Erasmus MC

Galectin-3, a marker of fibrosis, is associated with new-onset cancer and new-onset #HeartFailure in males, but not in females. bit.ly/3Z5zjgx #JACCCardioOnc #CardioOnc #CardioTwitter Wouter Meijers